Morgan Stanley set a GBX 9,000 ($122.05) price target on Reckitt Benckiser Group (LON:RB) in a research report sent to investors on Tuesday, January 9th. The firm currently has a buy rating on the stock.
Several other research analysts have also commented on the company. Kepler Capital Markets decreased their target price on Reckitt Benckiser Group from GBX 7,300 ($99.00) to GBX 7,000 ($94.93) and set a hold rating for the company in a research report on Monday, January 8th. JPMorgan Chase & Co. set a GBX 7,500 ($101.71) target price on Reckitt Benckiser Group and gave the stock a buy rating in a research report on Wednesday, January 3rd. Liberum Capital reiterated a buy rating and issued a GBX 8,000 ($108.49) target price on shares of Reckitt Benckiser Group in a research report on Tuesday, December 19th. Goldman Sachs Group set a GBX 7,070 ($95.88) target price on Reckitt Benckiser Group and gave the stock a neutral rating in a research report on Monday, December 11th. Finally, Barclays restated an equal weight rating and set a GBX 6,600 ($89.50) price objective (down previously from GBX 7,100 ($96.28)) on shares of Reckitt Benckiser Group in a research report on Monday, November 27th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have given a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of GBX 7,619.09 ($103.32).
Shares of Reckitt Benckiser Group (RB) traded up GBX 29 ($0.39) on Tuesday, hitting GBX 6,800 ($92.22). The stock had a trading volume of 911,488 shares, compared to its average volume of 1,120,000. The firm has a market cap of $47,860.00 and a price-to-earnings ratio of 2,274.25. Reckitt Benckiser Group has a one year low of GBX 6,299 ($85.42) and a one year high of GBX 8,110.43 ($109.99).
WARNING: This piece was first published by BBNS and is owned by of BBNS. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://baseballnewssource.com/markets/reckitt-benckiser-group-rb-given-a-gbx-9000-price-target-at-morgan-stanley/1823640.html.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.